XENT
Price:
$28.24
Market Cap:
$0
Intersect ENT, Inc. operates as an ear, nose, and throat (ENT) medical technology company in the United States. The company offers PROPEL, a steroid releasing implant to open the surgically enlarged sinus; PROPEL Mini, a releasing implant to treat patients undergoing frontal sinus surgery; and PROPEL Contour, a steroid releasing implant for the treatment of frontal and maxillary sinus ostia, or openings, of the dependent sinuses. It also provides SINUVA, a steroid releasing implant for the treatment of patients in the physician office setting; VENSURE Navigable and Stand-alone balloon, a sterile and single-use device, used to access and treat frontal, sphenoid sinus, and maxillary ostia in a...[Read more]
Industry
Medical - Devices
IPO Date
2014-07-24
Stock Exchange
NASDAQ
Ticker
XENT
According to Intersect ENT, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 103.66M. This represents a change of -88.77% compared to the average of 922.77M of the last 4 quarters.
The mean historical Enterprise Value of Intersect ENT, Inc. over the last ten years is 585.29M. The current 103.66M Enterprise Value has changed 1.67% with respect to the historical average. Over the past ten years (40 quarters), XENT's Enterprise Value was at its highest in in the March 2018 quarter at 1.16B. The Enterprise Value was at its lowest in in the March 2013 quarter at 0.
Average
585.29M
Median
662.78M
Minimum
191.42M
Maximum
1.01B
Discovering the peaks and valleys of Intersect ENT, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 180.01%
Maximum Annual Enterprise Value = 1.01B
Minimum Annual Increase = -39.68%
Minimum Annual Enterprise Value = 191.42M
| Year | Enterprise Value | Change |
|---|---|---|
| 2021 | 1.01B | 26.90% |
| 2020 | 797.71M | 3.36% |
| 2019 | 771.80M | -8.64% |
| 2018 | 844.76M | -8.54% |
| 2017 | 923.62M | 176.51% |
| 2016 | 334.02M | -39.68% |
| 2015 | 553.77M | 180.01% |
| 2014 | 197.77M | 3.32% |
| 2013 | 191.42M | -15.19% |
The current Enterprise Value of Intersect ENT, Inc. (XENT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
860.61M
5-year avg
870.04M
10-year avg
585.29M
Intersect ENT, Inc.’s Enterprise Value is less than Cardiovascular Systems, Inc. (797.83M), less than Gracell Biotechnologies Inc. (5.70B), less than Paragon 28, Inc. (1.17B), less than Silk Road Medical, Inc (1.18B), less than Poseida Therapeutics, Inc. (959.32M), less than Albireo Pharma, Inc. (677.78M), less than Verve Therapeutics, Inc. (966.13M), less than Apollo Endosurgery, Inc. (579.78M), less than Harpoon Therapeutics, Inc. (829.47M), less than VectivBio Holding AG (848.58M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 797.83M | $843.96M | |
| 5.70B | $989.87M | |
| 1.17B | $1.10B | |
| 1.18B | $1.12B | |
| 959.32M | $925.93M | |
| 677.78M | $915.89M | |
| 966.13M | $994.04M | |
| 579.78M | $579.72M | |
| 829.47M | $865.08M | |
| 848.58M | $1.06B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Intersect ENT, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Intersect ENT, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Intersect ENT, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Intersect ENT, Inc. (XENT)?
What is the 3-year average Enterprise Value for Intersect ENT, Inc. (XENT)?
What is the 5-year average Enterprise Value for Intersect ENT, Inc. (XENT)?
How does the current Enterprise Value for Intersect ENT, Inc. (XENT) compare to its historical average?